Bio-Techne, 908 Devices Partner on Protein Characterization
The firms said that pairing Bio-Techne's Maurice icIEF protein separation instrument with 908 Devices' ZipChip platform enables a workflow that increases scientists' drug development efficiency.
Bio-Techne Agrees to Buy ProteinSimple for $300M
NEW YORK (GenomeWeb) – Bio-Techne today announced a deal to buy protein analysis technology firm ProteinSimple for $300 million in cash.
ProteinSimple has appointed Joe Keegan and Chris van Ingen to its board of directors. Keegan was previously the CEO of ForteBio and Molecular Devices.
Quanterix this week launched a commercial, research-use-only version of its Single Molecule Array, Simoa, platform.
ProteinSimple said this week that it has hired Terry Salyer as vice president of sales.